Editor’s Note
**Editor’s Note:** Rohto Pharmaceutical expands its medical-exclusive DRX line with a new serum featuring poorly soluble azelaic acid in a smooth, lightweight formula. Available since July 21 at authorized hospitals and clinics nationwide at open prices.
Rohto Pharmaceutical has launched a new serum under its medical-exclusive brand ‘DRX’. The product incorporates the poorly soluble ingredient azelaic acid as-is, achieving a smooth and lightweight texture. It has been available at authorized hospitals and clinics nationwide since July 21 at open prices.
A new serum featuring the trending skincare ingredient azelaic acid has been introduced by the medical-exclusive brand ‘DRX’ from Rohto Pharmaceutical. The formulation directly incorporates the poorly soluble azelaic acid, delivering a lightweight and non-greasy feel. Since July 21, the product has been available at authorized hospitals and clinics across Japan at open prices.